REGENERON PHARMACEUTICALS

The current price of RGO is 827.184 CHF — it has decreased by 3.70% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on BX exchange REGENERON PHARMACEUTICALS stocks are traded under the ticker RGO.

REGENERON PHARMACEUTICALS is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.

RGO stock is 3.84% volatile and has beta coefficient of 0.54. Check out the list of the most volatile stocks — is REGENERON PHARMACEUTICALS there?

RGO earnings for the last quarter are 10.61 CHF per share, whereas the estimation was 9.78 CHF resulting in a 8.50% surprise. The estimated earnings for the next quarter are 9.03 CHF per share. See more details about REGENERON PHARMACEUTICALS earnings.

REGENERON PHARMACEUTICALS revenue for the last quarter amounts to ‪3.08 B‬ CHF despite the estimated figure of ‪2.96 B‬ CHF. In the next quarter revenue is expected to reach ‪2.77 B‬ CHF.

Yes, you can track REGENERON PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.

RGO stock has fallen by 3.70% compared to the previous week, the month change is a 1.55% fall, over the last year REGENERON PHARMACEUTICALS has showed a 19.35% increase.

Today REGENERON PHARMACEUTICALS has the market capitalization of ‪88.53 B‬, it has decreased by 0.38% over the last week.

No, RGO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, RGO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REGENERON PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.

RGO reached its all-time high on Mar 25, 2024 with the price of 871.173 CHF, and its all-time low was 531.540 CHF and was reached on Oct 26, 2021.
See other stocks reaching their highest and lowest prices.

As of Apr 27, 2024, the company has ‪13.45 K‬ employees. See our rating of the largest employees — is REGENERON PHARMACEUTICALS on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REGENERON PHARMACEUTICALS technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REGENERON PHARMACEUTICALS stock shows the sell signal. See more of REGENERON PHARMACEUTICALS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on REGENERON PHARMACEUTICALS future price: according to them, RGO price has a max estimate of 1088.95 CHF and a min estimate of 659.41 CHF. Read a more detailed REGENERON PHARMACEUTICALS forecast: see what analysts think of REGENERON PHARMACEUTICALS and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REGENERON PHARMACEUTICALS EBITDA is ‪3.96 B‬ CHF, and current EBITDA margin is 36.36%. See more stats in REGENERON PHARMACEUTICALS financial statements.